COVID-19's impact on cancer prevention and control in Africa

December 31, 2020

When the COVID-19 pandemic reached Africa, the continent was already struggling to deal with another public health crisis - a growing cancer epidemic characterized by more than one million new cancer cases and nearly 700,000 deaths per year. In a Perspective, Beatrice Wiafe Addai and Wilfred Ngwa discuss the significant challenges COVID-19 imposed on cancer prevention and control in Africa and how the efforts to address these challenges highlight key opportunities where greater investment could improve cancer care globally. At the start of the pandemic, many African governments were forced to rapidly divert already limited medical and healthcare resources away from cancer patients to treat those infected with SARS-CoV-2 and slow the spread of COVID-19. According to the authors, many African countries curtailed or cut cancer prevention activities, including awareness education and outreach, early detection screening, and vaccination, gaps that are likely to persist beyond the COVID-19 era. In addition, closed borders have made the international sharing of hospital-based resources and specialized lab diagnostics nearly impossible. Wiafa and Ngwa argue that, while necessary, this reallocation of critical health resources could lead to an increase in the number of late-stage cancer diagnoses and, thus, mortality across the continent. However, as many African nations have adapted to rise to these challenges, opportunities have also been created, such as cloud-based education and telemedicine, expansion of localized diagnostic capabilities and more efficient radiotherapy administration. The authors suggest that greater investment or policy in these areas could substantially increase access to cancer care worldwide.

For reporters interested in trends, a June 2020 Science Editorial by Norman E. Sharpless, director of the U.S. National Cancer Institute, addressed the likely impact of the pandemic on cancer mortality in the United States.

American Association for the Advancement of Science

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to